The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population

Rosanna Apa; Antonio Lanzone; Francesco Danilo Tiziano; Antonio Capalbo; Francesca Sagnella; Andrea Morciano; Francesca Moro; Daniela Martinez; Geraldina Neri; A. M. Fulghesu; A. Farcomeni; F. Spettu; A. Cappai; C. Carcassi

doi:10.1111/j.1365-2265.2012.04372.x

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population

Rosanna Apa, Antonio Lanzone, Francesco Danilo Tiziano, Antonio Capalbo, Francesca Sagnella, Andrea Morciano, Francesca Moro, Daniela Martinez, Geraldina Neri, A. M. Fulghesu, A. Farcomeni, F. Spettu, A. Cappai, C. Carcassi

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

33 Citazioni (Scopus)

Abstract

Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.

Lingua originale	English
pagine (da-a)	113-119
Numero di pagine	7
Rivista	Clinical Endocrinology
Volume	77
DOI	https://doi.org/10.1111/j.1365-2265.2012.04372.x
Stato di pubblicazione	Pubblicato - 2012

Keywords

polimorfismi

Accesso al documento

10.1111/j.1365-2265.2012.04372.x

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Apa, R., Lanzone, A., Tiziano, F. D., Capalbo, A., Sagnella, F., Morciano, A., Moro, F., Martinez, D., Neri, G., Fulghesu, A. M., Farcomeni, A., Spettu, F., Cappai, A., & Carcassi, C. (2012). The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population. Clinical Endocrinology, 77, 113-119. https://doi.org/10.1111/j.1365-2265.2012.04372.x

Apa, Rosanna ; Lanzone, Antonio ; Tiziano, Francesco Danilo ; Capalbo, Antonio ; Sagnella, Francesca ; Morciano, Andrea ; Moro, Francesca ; Martinez, Daniela ; Neri, Geraldina ; Fulghesu, A. M. ; Farcomeni, A. ; Spettu, F. ; Cappai, A. ; Carcassi, C. / The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population. In: Clinical Endocrinology. 2012 ; Vol. 77. pagg. 113-119.

@article{d5dfa529cbba4c65be219f8ce83612cb,

title = "The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population",

abstract = "Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.",

keywords = "polimorfismi, polimorfismi",

author = "Rosanna Apa and Antonio Lanzone and Tiziano, {Francesco Danilo} and Antonio Capalbo and Francesca Sagnella and Andrea Morciano and Francesca Moro and Daniela Martinez and Geraldina Neri and Fulghesu, {A. M.} and A. Farcomeni and F. Spettu and A. Cappai and C. Carcassi",

year = "2012",

doi = "10.1111/j.1365-2265.2012.04372.x",

language = "English",

volume = "77",

pages = "113--119",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "[Oxford]: [Blackwell Science].",

}

Apa, R , Lanzone, A , Tiziano, FD, Capalbo, A, Sagnella, F, Morciano, A, Moro, F, Martinez, D, Neri, G, Fulghesu, AM, Farcomeni, A, Spettu, F, Cappai, A & Carcassi, C 2012, 'The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population', Clinical Endocrinology, vol. 77, pagg. 113-119. https://doi.org/10.1111/j.1365-2265.2012.04372.x

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population. / Apa, Rosanna ; Lanzone, Antonio ; Tiziano, Francesco Danilo; Capalbo, Antonio; Sagnella, Francesca; Morciano, Andrea; Moro, Francesca; Martinez, Daniela; Neri, Geraldina; Fulghesu, A. M.; Farcomeni, A.; Spettu, F.; Cappai, A.; Carcassi, C.

In: Clinical Endocrinology, Vol. 77, 2012, pag. 113-119.

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

TY - JOUR

T1 - The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population

AU - Apa, Rosanna

AU - Lanzone, Antonio

AU - Tiziano, Francesco Danilo

AU - Capalbo, Antonio

AU - Sagnella, Francesca

AU - Morciano, Andrea

AU - Moro, Francesca

AU - Martinez, Daniela

AU - Neri, Geraldina

AU - Fulghesu, A. M.

AU - Farcomeni, A.

AU - Spettu, F.

AU - Cappai, A.

AU - Carcassi, C.

PY - 2012

Y1 - 2012

N2 - Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.

AB - Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.

KW - polimorfismi

UR - http://hdl.handle.net/10807/13093

U2 - 10.1111/j.1365-2265.2012.04372.x

DO - 10.1111/j.1365-2265.2012.04372.x

M3 - Article

VL - 77

SP - 113

EP - 119

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

ER -

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo